Increase in percent free prostate-specific antigen in men with chronic kidney disease.

Increase in percent free prostate-specific antigen in men with chronic kidney disease.

BACKGROUND: Prostate-specific antigen (PSA) occurs in different molecular forms in serum: free PSA (fPSA) and complexed PSA (cPSA), the sum of which corresponds to total PSA (tPSA). In addition to tPSA, percent fPSA is widely used in the detection of prostate cancer. Free PSA, approximately 28 kDa,...

Detaylı Bibliyografya
Asıl Yazarlar:	Bruun, L, Savage, C, Cronin, A, Hugosson, J, Lilja, H, Christensson, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2009

Benzer Materyaller

Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
Yazar:: Bruun, L, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.
Yazar:: Christensson, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
Yazar:: Christensson, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.
Yazar:: Bruun, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
Yazar:: Vickers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.
Yazar:: Bruun, L, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
Yazar:: Becker, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.
Yazar:: Savage, C, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
Yazar:: Aus, G, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1
Yazar:: Rui Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
Yazar:: Zackrisson, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
Yazar:: Becker, C, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
Yazar:: Becker, C, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
Yazar:: Vickers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
Yazar:: Dan Bee Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection.
Yazar:: Zackrisson, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).
Yazar:: Aus, G, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
Yazar:: Hugosson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

[Isoforms of free prostate-specific antigen]
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Isoforms of free prostate-specific antigen
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.
Yazar:: Vickers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.
Yazar:: Nurmikko, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml.
Yazar:: Rui Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.
Yazar:: Hugosson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Biology of prostate-specific antigen
Yazar:: Lilja, H
Baskı/Yayın Bilgisi: (2003)

Biology of prostate-specific antigen.
Yazar:: Lilja, H
Baskı/Yayın Bilgisi: (2003)

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
Yazar:: Hugosson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study.
Yazar:: Aus, G, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
Yazar:: Vickers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.
Yazar:: Ulmert, D, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function.
Yazar:: Ristiniemi, N, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
Yazar:: Vickers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
Yazar:: Evans-Axelsson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Ratios of Free to Total Prostate-Specific Antigen and Total Prostate Specific Antigen to Protein Concentrations in Saliva and Serum of Healthy Men
Yazar:: Fahimeh Kamalian, ve diğerleri
Baskı/Yayın Bilgisi: (2007-02-01)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
Yazar:: Klein, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.
Yazar:: Bergdahl, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
Yazar:: Jeremy YC Teoh, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable.
Yazar:: Zackrisson, B, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
Yazar:: Lilja, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
Yazar:: Törnblom, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)